Cargando…

Role of L-Type Amino Acid Transporter 1 (LAT1) for the Selective Cytotoxicity of Sesamol in Human Melanoma Cells

Sesamol is effective against melanoma cells with less damage to normal cells. The underlying selective cytotoxicity of sesamol in melanoma vs. non-cancerous cells is undefined. Melanoma cells differ from normal cells by over-expression of the L-type amino acid transporter 1 (LAT1). We sought to clar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srisongkram, Tarapong, Weerapreeyakul, Natthida, Kärkkäinen, Jussi, Rautio, Jarkko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865181/ https://www.ncbi.nlm.nih.gov/pubmed/31717859 http://dx.doi.org/10.3390/molecules24213869

Ejemplares similares

Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma
por: Srisongkram, Tarapong, et al.
Publicado: (2022)

Validation of Cell-Based Assay for Quantification of Sesamol Uptake and Its Application for Measuring Target Exposure
por: Srisongkram, Tarapong, et al.
Publicado: (2019)

Tyrosine–Chlorambucil Conjugates Facilitate Cellular Uptake through L-Type Amino Acid Transporter 1 (LAT1) in Human Breast Cancer Cell Line MCF-7
por: Pocasap, Piman, et al.
Publicado: (2020)

Evaluation of Melanoma (SK-MEL-2) Cell Growth between Three-Dimensional (3D) and Two-Dimensional (2D) Cell Cultures with Fourier Transform Infrared (FTIR) Microspectroscopy
por: Srisongkram, Tarapong, et al.
Publicado: (2020)

Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
por: Srisongkram, Tarapong, et al.
Publicado: (2022)

StackBRAF: A Large-Scale Stacking Ensemble Learning for BRAF Affinity Prediction
por: Syahid, Nur Fadhilah, et al.
Publicado: (2023)

Machine Learning and In Vitro Chemical Screening of Potential α-Amylase and α-Glucosidase Inhibitors from Thai Indigenous Plants
por: Srisongkram, Tarapong, et al.
Publicado: (2022)

Phytochemical Screening on Phenolic, Flavonoid Contents, and Antioxidant Activities of Six Indigenous Plants Used in Traditional Thai Medicine
por: Tiranakwit, Tanawuth, et al.
Publicado: (2023)

Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates
por: Bahrami, Katayun, et al.
Publicado: (2022)

Bioactive Compounds, Antioxidant Activities, and HPLC Analysis of Nine Edible Sprouts in Cambodia
por: So, Visessakseth, et al.
Publicado: (2023)

Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
por: Barollo, Susi, et al.
Publicado: (2016)

The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer
por: Salisbury, Travis B, et al.
Publicado: (2018)

The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
por: Häfliger, Pascal, et al.
Publicado: (2019)

The L-type Amino Acid Transporter (LAT1) Expression in Patients with Scoliosis
por: Demura, Satoru, et al.
Publicado: (2021)

Cytotoxicity and Apoptosis Induction of Coumarins and Carbazole Alkaloids from Clausena Harmandiana
por: Jantamat, Porntip, et al.
Publicado: (2019)

l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
por: Huttunen, Johanna, et al.
Publicado: (2019)

Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno‐foetal amino acid transport
por: Zaugg, Jonas, et al.
Publicado: (2020)

Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET
por: Ikotun, Oluwatayo F., et al.
Publicado: (2013)

Positive Regulation of Decidualization by l-Type Amino Acid Transporter 1 (lat1) in Pregnant Mice
por: Wang, Xiaojie, et al.
Publicado: (2016)

Vitamin D stimulates placental L-type amino acid transporter 1 (LAT1) in preeclampsia
por: Jia, Xiaotong, et al.
Publicado: (2022)

Chemical Composition, Antioxidant and Cytotoxicity Activities of Leaves, Bark, Twigs and Oleo-Resin of Dipterocarpus alatus
por: Yongram, Chawalit, et al.
Publicado: (2019)

Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands
por: Huttunen, Johanna, et al.
Publicado: (2021)

Anti‐tumor effects of mAb against l‐type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes
por: Ueda, Shiho, et al.
Publicado: (2019)

L-type amino acid transporter (LAT) 1 expression in (18)F-FET-negative gliomas
por: Vettermann, Franziska J., et al.
Publicado: (2021)

Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma
por: Cormerais, Yann, et al.
Publicado: (2019)

Dipterocarpol in Oleoresin of Dipterocarpus alatus Attributed to Cytotoxicity and Apoptosis-Inducing Effect
por: Puthongking, Ploenthip, et al.
Publicado: (2022)

Formulation, Characterization, Anti-Inflammatory and Cytotoxicity Study of Sesamol-Laden Nanosponges
por: Nair, Anroop B., et al.
Publicado: (2022)

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
por: Shi, Zitong, et al.
Publicado: (2023)

Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
por: Isoda, Atsushi, et al.
Publicado: (2014)

Characterisation of L-Type Amino Acid Transporter 1 (LAT1) Expression in Human Skeletal Muscle by Immunofluorescent Microscopy
por: Hodson, Nathan, et al.
Publicado: (2017)

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2022)

Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer
por: Shindo, Haruhiko, et al.
Publicado: (2021)

Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1
por: Singh, Natesh, et al.
Publicado: (2018)

Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2023)

Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter
por: Yan, Renhong, et al.
Publicado: (2021)

Ubiquitylation and endocytosis of the human LAT1/SLC7A5 amino acid transporter
por: Barthelemy, Céline, et al.
Publicado: (2019)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain
por: Hugele, Agathe, et al.
Publicado: (2022)

Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods
por: Singh, Natesh, et al.
Publicado: (2018)

The Evaluation of l‐Tryptophan Derivatives as Inhibitors of the l‐Type Amino Acid Transporter LAT1 (SLC7A5)
por: Graff, Julien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2frfr60mju48f868jupno35ksr